Vitamin Shoppe Inc (NYSE:VSI) major shareholder Vintage Capital Management Llc acquired 234,343 shares of the firm’s stock in a transaction dated Saturday, December 29th. The shares were acquired at an average price of $4.36 per share, for a total transaction of $1,021,735.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
Vintage Capital Management Llc also recently made the following trade(s):
- On Friday, January 5th, Vintage Capital Management Llc acquired 326,692 shares of Vitamin Shoppe stock. The shares were acquired at an average price of $4.96 per share, for a total transaction of $1,620,392.32.
- On Tuesday, January 2nd, Vintage Capital Management Llc acquired 133,804 shares of Vitamin Shoppe stock. The shares were acquired at an average price of $4.28 per share, for a total transaction of $572,681.12.
Vitamin Shoppe Inc (NYSE VSI) opened at $4.90 on Friday. Vitamin Shoppe Inc has a 52-week low of $2.95 and a 52-week high of $23.85. The firm has a market capitalization of $121.09, a price-to-earnings ratio of -0.46 and a beta of 0.68. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.07 and a quick ratio of 0.32.
Vitamin Shoppe (NYSE:VSI) last announced its quarterly earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.20). The firm had revenue of $288.20 million during the quarter, compared to analysts’ expectations of $297.61 million. Vitamin Shoppe had a positive return on equity of 6.17% and a negative net margin of 20.27%. The company’s quarterly revenue was down 8.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.50 earnings per share. analysts predict that Vitamin Shoppe Inc will post 0.34 earnings per share for the current fiscal year.
Several equities research analysts have recently issued reports on VSI shares. Zacks Investment Research upgraded Vitamin Shoppe from a “sell” rating to a “hold” rating in a report on Wednesday, October 25th. ValuEngine lowered Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Morgan Stanley cut their target price on Vitamin Shoppe from $7.50 to $4.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 9th. Finally, Barclays cut their target price on Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 9th. Four research analysts have rated the stock with a sell rating and five have given a hold rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $5.00.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Macquarie Group Ltd. purchased a new stake in Vitamin Shoppe in the third quarter valued at approximately $101,000. BNP Paribas Arbitrage SA raised its stake in Vitamin Shoppe by 2.1% in the second quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock valued at $108,000 after purchasing an additional 192 shares in the last quarter. Municipal Employees Retirement System of Michigan raised its stake in Vitamin Shoppe by 18.1% in the second quarter. Municipal Employees Retirement System of Michigan now owns 9,410 shares of the specialty retailer’s stock valued at $110,000 after purchasing an additional 1,440 shares in the last quarter. Wolverine Trading LLC purchased a new stake in Vitamin Shoppe in the second quarter valued at approximately $131,000. Finally, UBS Asset Management Americas Inc. raised its stake in Vitamin Shoppe by 17,041.4% in the second quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock valued at $140,000 after purchasing an additional 11,929 shares in the last quarter. 90.35% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: This piece of content was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another site, it was stolen and reposted in violation of US and international copyright law. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/01/13/vitamin-shoppe-inc-vsi-major-shareholder-buys-1021735-48-in-stock.html.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.